| News - CNIO
Let

Home | News

News

Oncologist Joaquín Martínez (center in the first row) with his team from the H12O-CNIO Haematological Malignancies Clinical Research Unit and the Confocal Microscopy Unit led by Diego Megías (first left in the second row), which has also collaborated in the project. /Laura M. Lombardy. CNIO Translational
 06.10.2021 Blood Cancer Journal. Researchers at CNIO and 12 de Octubre Hospital prove efficacy of new immunotherapy for multiple myeloma CAR-T cell immunotherapy is a huge step forward in the treatment of blood cancer. However, it can... Events
 29.09.2021 Hundreds of children and young people conduct experiments together with CNIO scientists during European Researchers’ Night During a virtual meeting entitled ‘Meet the scientists, be a scientist’,the Spanish National... Día Mundial Investigación Cáncer Events
 24.09.2021 Mariano Esteban: “New technologies used against COVID-19 will accelerate cancer immunotherapies and vaccines” “In Spain, we need to reinforce the confidence that we have good researchers and healthcare... Fondation Franz Weber gives CNIO funding to attract scientific talent for using alternative techniques to animal testing in cancer research 09.09.2021 Fondation Franz Weber gives CNIO funding to attract scientific talent for using alternative techniques to animal testing in cancer research By virtue of the cooperation agreement signed by Fondation Franz Weber and the Spanish National... Basic Research
 17.08.2021 eLife. A master regulator gene for brain cancer with the worst prognosis Researchers at the CNIO and scientists from the School of Medicine of the University of Fribourg,... CNIO Friend Newsletter CNIO Friends
 06.08.2021 CNIO Friends newsletter 39 21.07.2021 CNIO receives support from “la Caixa” Foundation to study obesity and some of the most common tumours Alejo Efeyan, a researcher at the Spanish National Cancer Research Centre (CNIO) will head up the... Tumor pulmonar inducido por el KRAS4A. /CNIO Basic Research
 19.07.2021 PNAS. CNIO researchers clarify the role of the two isoforms of KRAS, the most common oncogene in human cancer KRAS was one of the first oncogenes to be identified, a few decades ago. It is among the most common... From left to right: Ruth Toledano, Maria A. Blasco, Rafael Rodrigo and Leonardo Anselmi at the agreement signing event. /CNIO 16.07.2021 CNIO and Fondation Franz Weber to cooperate in the promotion of research alternatives to animal testing The Spanish National Cancer Research Centre (CNIO) and Fondation Franz Weber have signed an...
1 2 3 … 59

Up